Document 3286 DOCN M94A3286 TI The cytoskeletal proteins cleaving activity of the recombinant HIV-1 protease. DT 9412 AU Azuma R; Furuishi K; Saito A; Shinagawa H; Ikeda S; Shoji S; Dept. of Biochem., Fac. of Pharm. Sci., Kumamoto Univ., Japan. SO Int Conf AIDS. 1994 Aug 7-12;10(1):110 (abstract no. PA0059). Unique Identifier : AIDSLINE ICA10/94369289 AB OBJECTIVE: The purpose of the present work was to isolate a HIV-1 protease from HIV-1 protease expressing E. coli, and to determine its enzymatic activity for synthetic oligopeptides and nonviral protein substrates. METHODS: HIV-1 protease expressing E. coli was lysed, extracted, and partially purified by DEAE-Cellulofine and SP-Toyopearl column chromatography. The enzymatic cleaving activities for synthetic oligopeptides and proteins were determined by HPLC and SDS-PAGE, respectively. RESULTS AND DISCUSSION: The HIV-1 protease was separated from the HIV-1 protease expressing E. coli. It cleaved the Tyr-Pro bond of the various oligopeptides, and had a pH optimum at pH 5.5 for suc-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln. It was strongly inhibited by pepstatin A. The enzyme specifically hydrolyzed a Phe-Ala bond of alpha-actinin which is a component of cytoskeltal proteins. The enzyme may be important for penetration of the virus into the host cells in addition to the key enzyme in HIV-1 gag protein processing. DE Amino Acid Sequence Binding Sites Cytoskeletal Proteins/GENETICS/*METABOLISM Escherichia coli/GENETICS Human Hydrogen-Ion Concentration HIV Protease/GENETICS/*METABOLISM HIV-1/*ENZYMOLOGY/GENETICS In Vitro Molecular Sequence Data Oligopeptides/CHEMICAL SYNTHESIS/GENETICS/METABOLISM Recombinant Proteins/GENETICS/METABOLISM Substrate Specificity MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).